BE471121A - - Google Patents
Info
- Publication number
- BE471121A BE471121A BE471121DA BE471121A BE 471121 A BE471121 A BE 471121A BE 471121D A BE471121D A BE 471121DA BE 471121 A BE471121 A BE 471121A
- Authority
- BE
- Belgium
- Prior art keywords
- vitamin
- lactoflavin
- solution
- acid
- sep
- Prior art date
Links
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 3
- 150000007530 organic bases Chemical class 0.000 claims description 3
- WXTMDXOMEHJXQO-UHFFFAOYSA-N Gentisic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 25
- 239000000243 solution Substances 0.000 description 15
- 229960002477 Riboflavin Drugs 0.000 description 13
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 13
- 229960005219 gentisic acid Drugs 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 11
- 239000011780 sodium chloride Substances 0.000 description 11
- 229920001098 polystyrene-block-poly(ethylene/propylene) Polymers 0.000 description 10
- 239000002904 solvent Substances 0.000 description 7
- UIIMBOGNXHQVGW-UHFFFAOYSA-M NaHCO3 Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 229930003451 Vitamin B1 Natural products 0.000 description 5
- 229960003495 thiamine Drugs 0.000 description 5
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 5
- 235000010374 vitamin B1 Nutrition 0.000 description 5
- 239000011691 vitamin B1 Substances 0.000 description 5
- 229940029983 VITAMINS Drugs 0.000 description 4
- 229930003268 Vitamin C Natural products 0.000 description 4
- 229940021016 Vitamin IV solution additives Drugs 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- 239000001569 carbon dioxide Substances 0.000 description 4
- 229910002092 carbon dioxide Inorganic materials 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- 235000019154 vitamin C Nutrition 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 150000003700 vitamin C derivatives Chemical class 0.000 description 4
- 229930003231 vitamins Natural products 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OSASVXMJTNOKOY-UHFFFAOYSA-N Chlorobutanol Chemical compound CC(C)(O)C(Cl)(Cl)Cl OSASVXMJTNOKOY-UHFFFAOYSA-N 0.000 description 3
- 229960004926 Chlorobutanol Drugs 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- DFPAKSUCGFBDDF-UHFFFAOYSA-N nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 3
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 3
- 235000017557 sodium bicarbonate Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N Benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000005711 Benzoic acid Substances 0.000 description 2
- 229940055726 Pantothenic Acid Drugs 0.000 description 2
- 229940011671 Vitamin B6 Drugs 0.000 description 2
- 229930003629 Vitamin B6 Natural products 0.000 description 2
- 239000003929 acidic solution Substances 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- JCXJVPUVTGWSNB-UHFFFAOYSA-N nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 description 2
- 235000019161 pantothenic acid Nutrition 0.000 description 2
- GHOKWGTUZJEAQD-ZETCQYMHSA-N pantothenic acid Natural products OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 239000011713 pantothenic acid Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000011726 vitamin B6 Substances 0.000 description 2
- 235000019158 vitamin B6 Nutrition 0.000 description 2
- 150000003697 vitamin B6 derivatives Chemical class 0.000 description 2
- 229940035674 ANESTHETICS Drugs 0.000 description 1
- 229940064004 Antiseptic throat preparations Drugs 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-isoascorbic acid Chemical compound OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- 229940068459 SODIUM PANTOTHENATE Drugs 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Vitamin C Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating Effects 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 150000001346 alkyl aryl ethers Chemical class 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 230000003444 anaesthetic Effects 0.000 description 1
- 230000002421 anti-septic Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 101710006880 cgR_0192 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- ROSDSFDQCJNGOL-UHFFFAOYSA-N dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- BAVYZALUXZFZLV-UHFFFAOYSA-N methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 1
- YNAVUWVOSKDBBP-UHFFFAOYSA-N morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 1
- 229940113083 morpholine Drugs 0.000 description 1
- 230000001264 neutralization Effects 0.000 description 1
- -1 nicotylamide Natural products 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003638 reducing agent Substances 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 239000001187 sodium carbonate Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001225 therapeutic Effects 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BE471121A true BE471121A (es) |
Family
ID=121076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BE471121D BE471121A (es) |
Country Status (1)
| Country | Link |
|---|---|
| BE (1) | BE471121A (es) |
-
0
- BE BE471121D patent/BE471121A/fr unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5108517B2 (ja) | 治療活性剤、クエン酸または共役塩基、および二酸化塩素を含む安定化された組成物 | |
| CA2243946C (en) | Reducing electrolyzed water and method for producing same | |
| CN106727291A (zh) | 一种盐酸托莫西汀口服溶液及其制备方法 | |
| JPH0347161A (ja) | ５―アミノサリチル酸の安定な液体形 | |
| EP1343473B1 (fr) | Composition pharmaceutique de dronedarone pour administration parenterale | |
| BE471121A (es) | ||
| BE1001527A6 (fr) | Preparation aqueuse stabilisee d'acide folique. | |
| US20080073291A1 (en) | Agents and methods for removing chloramine, chlorine, and other active chlorine compounds from water used for keeping water organisms | |
| WO2007045256A1 (fr) | Composition comprenant un alkylsiliconate hydrophobant contenant au moins un indicateur | |
| KR20060130140A (ko) | 안정하고, 미감이 향상된 이부프로펜 함유 시럽 및 그 제법 | |
| EP0830144B1 (fr) | Compositions pulverulentes et solubles dans l'eau et leurs applications | |
| RU2372904C2 (ru) | Композиция альфа-липоевой (тиоктовой) кислоты, способ ее получения и способ лечения | |
| US20230077014A1 (en) | Compositions and methods related to pharmaceutical excipients | |
| EP0230199B1 (fr) | Nouveaux sels ferriques complexes de l'acide alpha, alpha'-(1,2-éthanodihylodiimine)-bis[5-carboxy-2-hydroxybenzénoacétique], et leur procédé de préparation | |
| BE821696A (fr) | Procede de preparation d'une formulation stable contenant une prostaglandine du groupe e | |
| RU2115420C1 (ru) | Твердое вещество для приготовления окислительного раствора и способ его получения | |
| BE530825A (es) | ||
| BE515081A (es) | ||
| BE592400A (es) | ||
| CH371216A (fr) | Procédé de préparation d'un produit vitaminé aqueux | |
| JPH027319B2 (es) | ||
| BE398503A (es) | ||
| BE897574Q (fr) | Composition de fer permettant d'elever la concentration en fer du sang d'un mammifere et son procede de preparation | |
| JP2003517415A (ja) | 過酸化水素用リンモリブデン酸安定剤 | |
| DuMond et al. | P64. Administration of oral nitrite and cardiac dysfunction following pressure overload induced hypertrophy–A preliminary study |